SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?


To: Tunica Albuginea who wrote (5172)1/31/1998 11:12:00 AM
From: Gene Voss  Respond to of 23519
 
TA

Right now I'm working with a group of compounding pharmacists, but, hope to introduce it to Vivus soon. If nothing else I'm very encouraged by the results we've seen using the transurethal administration approach. I hope to discuss our findings soon. Vivus has the means and intellectual property necessary to really improve on their current product. Efficacy should be significantly improved with time.

GV